These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32063212)

  • 21. Peritoneal Dialysis Prescription and Adequacy in Clinical Practice: Core Curriculum 2023.
    Auguste BL; Bargman JM
    Am J Kidney Dis; 2023 Jan; 81(1):100-109. PubMed ID: 36208963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adequate peritoneal dialysis--new guidelines?].
    Lilaj T
    Wien Klin Wochenschr; 2005; 117 Suppl 6():83-8. PubMed ID: 16437338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing high-quality peritoneal dialysis: Moving beyond urea clearance.
    Glavinovic T; Hurst H; Hutchison A; Johansson L; Ruddock N; Perl J
    Perit Dial Int; 2020 May; 40(3):293-301. PubMed ID: 32063213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five Things to Know About Incremental Peritoneal Dialysis.
    Qureshi MA; Hamidi S; Auguste BL
    Can J Kidney Health Dis; 2023; 10():20543581231192748. PubMed ID: 37577176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The
    Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Johnson DW;
    Perit Dial Int; 2017; 37(3):283-289. PubMed ID: 27935537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphate clearance in peritoneal dialysis: automated PD compared with continuous ambulatory PD.
    Sawin DA; Himmele R; Diaz-Buxo JA
    Adv Perit Dial; 2012; 28():120-5. PubMed ID: 23311227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single Daily Icodextrin Exchange as Initial and Solitary Therapy.
    Agar BU; Sloand JA
    Perit Dial Int; 2018; 38(2):119-124. PubMed ID: 29386305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental Versus Standard (Full-Dose) Peritoneal Dialysis.
    Cheetham MS; Cho Y; Krishnasamy R; Jain AK; Boudville N; Johnson DW; Huang LL
    Kidney Int Rep; 2022 Feb; 7(2):165-176. PubMed ID: 35155856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
    Hashimoto Y; Matsubara T
    Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Change in Peritoneal Function in Patients on Continuous Ambulatory PD vs Automated PD.
    Samad N; Fan SL
    Perit Dial Int; 2017; 37(6):627-632. PubMed ID: 28970363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient Education and Peritoneal Dialysis Modality Selection: A Systematic Review and Meta-analysis.
    Devoe DJ; Wong B; James MT; Ravani P; Oliver MJ; Barnieh L; Roberts DJ; Pauly R; Manns BJ; Kappel J; Quinn RR
    Am J Kidney Dis; 2016 Sep; 68(3):422-33. PubMed ID: 27125246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Person-centered peritoneal dialysis prescription and the role of shared decision-making.
    Blake PG; Brown EA
    Perit Dial Int; 2020 May; 40(3):302-309. PubMed ID: 32063218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription.
    Lew SQ
    Adv Perit Dial; 2018 Nov; 34(2018):10-14. PubMed ID: 30480530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dialysis Patient-Centeredness and Precision Medicine: Focus on Incremental Home Hemodialysis and Preserving Residual Kidney Function.
    Gedney N; Kalantar-Zadeh K
    Semin Nephrol; 2018 Jul; 38(4):426-432. PubMed ID: 30082062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incremental peritoneal dialysis and survival outcomes: a propensity-matched cohort study.
    Liu R; Ye H; Peng Y; Yi C; Lin J; Wu H; Diao X; Mao H; Huang F; Yang X
    J Nephrol; 2023 Sep; 36(7):1907-1919. PubMed ID: 37603146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial.
    Howard K; Hayes A; Cho Y; Cass A; Clarke M; Johnson DW
    Am J Kidney Dis; 2015 May; 65(5):773-9. PubMed ID: 25746151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incremental peritoneal dialysis: effects on the choice of dialysis modality, residual renal function and adequacy.
    Viglino G; Neri L; Barbieri S
    Kidney Int Suppl; 2008 Apr; (108):S52-5. PubMed ID: 18379548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental peritoneal dialysis: Is it better for preservation of residual kidney function and clinical outcomes?
    Fernandes A; Matias P; Branco P
    Clin Nephrol; 2023 Jan; 99(1):11-17. PubMed ID: 36472405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.